Archive for April 2009
I started a similar web site in French on:
The Best of the Web column has become one of GEN‘s (Genetic Engineering & Biotechnology News) most popular features. So (they) have created a database of past reviews, making it quick and easy for you to find websites in a specific category of interest.
My opinion: What I appreciate is that each site is commented (strong and weak points) and rated by the editor. It is not a new directory with plenty of websites: only a few sites are referenced by category and each selection is an high-quality resource. The selection is of course biotech-oriented but not only: I would recommend the category “Databases” which is full of must-know web sites …
Science Intelligence can be defined as the combination of Technics, Methods and Tools used by an organization to watch its scientific environment, in order to maintain its level of knowledge and to face its various challenging issues.
It includes process of gathering, storing and analyzing the information. It is about making the company more innovative, more efficient, more compliant and more competitive.
Once collected, business information and data have to be converted into intelligence and re-used to drive business decision making.
David Crotty, a science blogger, wrote this fundamental post in 2008:
“If you spend much time in the science blogosphere, everyone seems to be talking about these great tools and the changes they’re making in research science. But when you step away from the enthusiasts and speak with the majority of scientists, you find out that they don’t have much interest in using many of these new technologies”
- Lack of time: potential users are overscheduled and overworked: they are already completely overloaded by current literature to digest
- Authors of blogs or contributions are rarely prominent researchers: those prefer classic channels (books, prestigious journals, congresses) which are more incentive, more lucrative, more prestigious
- No business model behind
- Need a high level of participation! If they are users-created content, so No users = no content (and the circle goes around)
- A confused « market »: too many sites for a same purpose: Connotea, CiteUlike, etc.
- Usability (the Ipod model)
- Services are inappropriate to the Scientists culture: « Scientists don’t find collaborators by chatting online with strangers»
- Scientists use social networks to find a job (LinkedIn) not to chat with friends
- Science Blogs are only read by other Science bloggers, students, non-scientists/non specialists and journalists
- Flaws of Blogs: « me to » (too much with the same information) + « I do » (too ego-centered)
Crotty, David. Why Web 2.O is failing in Biology. Bench Marks blog, online, Feb. 2008: http://www.cshblogs.org/cshprotocols/2008/02/14/why-web-20-is-failing-in-biology/
I would complete with: accumulation of Private stuffs, non-relevant widgets, links to commercial shops, etc. All these non-relevant things have also contributed to lack of credibility.
DailyMed provides high quality information about marketed drugs. This information includes FDA approved labels (package inserts). This Web site provides health information providers and the public with a standard, comprehensive, up-to-date, look-up and download resource of medication content and labeling as found in medication package inserts:
84% of Researchers consider that it is “vital or extremely vital to access the Work and experiences of their peers”
Adapted of: The Accountability of ScienceDirect, White paper, 2008, www.elsevierforindustry.com
For the Pharmaceutical Industry, Science Intelligence is
- Science Awareness (Science advances, New Drug discovery, etc.)
- Technological Watch (Biotechnologies, Innovation for packaging, formulations, etc.)
- Business Intelligence (Competitors monitoring, Business opportunities, etc.)
- Regulatory watch (Authorities guidelines, protocols, Good practices, etc.)
- Post-Marketing surveillance (clinical data, etc.)